HETEROCICLOS SUSBSTITUIDOS, NOMEADAMENTE DERIVADOS DE QUINAZOLINA, PROCESSO PARA A SUA PREPARACAO E SUA UTILIZACAO

There are disclosed compounds of the general formula I: I wherein A is -CR7=CR8-; Z is -CR7=CR8-; X is H, NR 9R10, OR11, CN, F, Cl, I, Br, perfluoroalkyl, alkyl,alkoxy, alkyl-OH, alkoxyalkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; Y is NR13,NR13CR12R14, CR12R14NR13; R1 is 5-tetrazolyl, CO2R11,SO3H, NHSO2CH3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JOHN LAURENT PRIMEAU, LLOYD MICHAEL GARRICK
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JOHN LAURENT PRIMEAU
LLOYD MICHAEL GARRICK
description There are disclosed compounds of the general formula I: I wherein A is -CR7=CR8-; Z is -CR7=CR8-; X is H, NR 9R10, OR11, CN, F, Cl, I, Br, perfluoroalkyl, alkyl,alkoxy, alkyl-OH, alkoxyalkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; Y is NR13,NR13CR12R14, CR12R14NR13; R1 is 5-tetrazolyl, CO2R11,SO3H, NHSO2CH3, NHSO2CF3; R2,R3,R4,R7R8 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R13, -(CH2)nCO2R11,-(CH2)nCONR9R10, OR11,F,Cl,Br,I,NR9R10; R5 is alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, H, -CN, NO2, SO2R13,-(CH2)nCO2R11, -(CH2)nCONR9R10, -OH,OR11,F,Cl,Br,I,NR9R10; R9,R10 is H, alkyl, alkoxyalkyl,alkyl-OH, perfluoroalkyl, aralkyl; R11 is H, alkyl, aralkyl, alkoxyalkyl; R12,R14 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R13, -(CH2)nCO2R11, -(CH2)nCONR9R10; R13 is H, OR11, alkyl, perfluoroalkyl, aralkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; wherein alkyl is defined as 1-8 carbons, branched or straight chain; perfluoroalkyl is defined as 1-6 carbons; aralkyl is defined as 7-12 carbons or 7-12 carbons substituted with fluorine, bromine or chlorine and the phamaceutically acceptable salts, solvates and hydrates thereof, which by virtue of their ability to antagonize angiotensin II are useful for the treatment of hypertension and congestive heart-failure. The compounds are also useful for reducing lipid levels in the blood plasma and are thus useful for treating hyperlipidemia and hypercholesterolemia. Also disclosed are processes for the production of said compounds and pharmaceutical compositions containing said compounds.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT100993B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT100993B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT100993B3</originalsourceid><addsrcrecordid>eNqFjLEOgkAQRGksjPoLZj8AEwwV5XKsYRNgkb2zoCHEnJVRIv5_PIy9zczOy-yso1dJljoxbCpRUKe5WraOC9EYGqkJC6ypsQQFdXzBwMMFZ8cN9lIFjaEN_6Qq0GKHgGEFA6MlGRSgL3CWK-4XsI1Wt_E--93PN9H-RNaUBz89Bz9P49U__Hto7TFJsizN07-FDy78N2g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCICLOS SUSBSTITUIDOS, NOMEADAMENTE DERIVADOS DE QUINAZOLINA, PROCESSO PARA A SUA PREPARACAO E SUA UTILIZACAO</title><source>esp@cenet</source><creator>JOHN LAURENT PRIMEAU ; LLOYD MICHAEL GARRICK</creator><creatorcontrib>JOHN LAURENT PRIMEAU ; LLOYD MICHAEL GARRICK</creatorcontrib><description>There are disclosed compounds of the general formula I: I wherein A is -CR7=CR8-; Z is -CR7=CR8-; X is H, NR 9R10, OR11, CN, F, Cl, I, Br, perfluoroalkyl, alkyl,alkoxy, alkyl-OH, alkoxyalkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; Y is NR13,NR13CR12R14, CR12R14NR13; R1 is 5-tetrazolyl, CO2R11,SO3H, NHSO2CH3, NHSO2CF3; R2,R3,R4,R7R8 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R13, -(CH2)nCO2R11,-(CH2)nCONR9R10, OR11,F,Cl,Br,I,NR9R10; R5 is alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, H, -CN, NO2, SO2R13,-(CH2)nCO2R11, -(CH2)nCONR9R10, -OH,OR11,F,Cl,Br,I,NR9R10; R9,R10 is H, alkyl, alkoxyalkyl,alkyl-OH, perfluoroalkyl, aralkyl; R11 is H, alkyl, aralkyl, alkoxyalkyl; R12,R14 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R13, -(CH2)nCO2R11, -(CH2)nCONR9R10; R13 is H, OR11, alkyl, perfluoroalkyl, aralkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; wherein alkyl is defined as 1-8 carbons, branched or straight chain; perfluoroalkyl is defined as 1-6 carbons; aralkyl is defined as 7-12 carbons or 7-12 carbons substituted with fluorine, bromine or chlorine and the phamaceutically acceptable salts, solvates and hydrates thereof, which by virtue of their ability to antagonize angiotensin II are useful for the treatment of hypertension and congestive heart-failure. The compounds are also useful for reducing lipid levels in the blood plasma and are thus useful for treating hyperlipidemia and hypercholesterolemia. Also disclosed are processes for the production of said compounds and pharmaceutical compositions containing said compounds.</description><edition>6</edition><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990730&amp;DB=EPODOC&amp;CC=PT&amp;NR=100993B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990730&amp;DB=EPODOC&amp;CC=PT&amp;NR=100993B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOHN LAURENT PRIMEAU</creatorcontrib><creatorcontrib>LLOYD MICHAEL GARRICK</creatorcontrib><title>HETEROCICLOS SUSBSTITUIDOS, NOMEADAMENTE DERIVADOS DE QUINAZOLINA, PROCESSO PARA A SUA PREPARACAO E SUA UTILIZACAO</title><description>There are disclosed compounds of the general formula I: I wherein A is -CR7=CR8-; Z is -CR7=CR8-; X is H, NR 9R10, OR11, CN, F, Cl, I, Br, perfluoroalkyl, alkyl,alkoxy, alkyl-OH, alkoxyalkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; Y is NR13,NR13CR12R14, CR12R14NR13; R1 is 5-tetrazolyl, CO2R11,SO3H, NHSO2CH3, NHSO2CF3; R2,R3,R4,R7R8 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R13, -(CH2)nCO2R11,-(CH2)nCONR9R10, OR11,F,Cl,Br,I,NR9R10; R5 is alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, H, -CN, NO2, SO2R13,-(CH2)nCO2R11, -(CH2)nCONR9R10, -OH,OR11,F,Cl,Br,I,NR9R10; R9,R10 is H, alkyl, alkoxyalkyl,alkyl-OH, perfluoroalkyl, aralkyl; R11 is H, alkyl, aralkyl, alkoxyalkyl; R12,R14 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R13, -(CH2)nCO2R11, -(CH2)nCONR9R10; R13 is H, OR11, alkyl, perfluoroalkyl, aralkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; wherein alkyl is defined as 1-8 carbons, branched or straight chain; perfluoroalkyl is defined as 1-6 carbons; aralkyl is defined as 7-12 carbons or 7-12 carbons substituted with fluorine, bromine or chlorine and the phamaceutically acceptable salts, solvates and hydrates thereof, which by virtue of their ability to antagonize angiotensin II are useful for the treatment of hypertension and congestive heart-failure. The compounds are also useful for reducing lipid levels in the blood plasma and are thus useful for treating hyperlipidemia and hypercholesterolemia. Also disclosed are processes for the production of said compounds and pharmaceutical compositions containing said compounds.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjLEOgkAQRGksjPoLZj8AEwwV5XKsYRNgkb2zoCHEnJVRIv5_PIy9zczOy-yso1dJljoxbCpRUKe5WraOC9EYGqkJC6ypsQQFdXzBwMMFZ8cN9lIFjaEN_6Qq0GKHgGEFA6MlGRSgL3CWK-4XsI1Wt_E--93PN9H-RNaUBz89Bz9P49U__Hto7TFJsizN07-FDy78N2g</recordid><startdate>19990730</startdate><enddate>19990730</enddate><creator>JOHN LAURENT PRIMEAU</creator><creator>LLOYD MICHAEL GARRICK</creator><scope>EVB</scope></search><sort><creationdate>19990730</creationdate><title>HETEROCICLOS SUSBSTITUIDOS, NOMEADAMENTE DERIVADOS DE QUINAZOLINA, PROCESSO PARA A SUA PREPARACAO E SUA UTILIZACAO</title><author>JOHN LAURENT PRIMEAU ; LLOYD MICHAEL GARRICK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT100993B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>1999</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JOHN LAURENT PRIMEAU</creatorcontrib><creatorcontrib>LLOYD MICHAEL GARRICK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOHN LAURENT PRIMEAU</au><au>LLOYD MICHAEL GARRICK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCICLOS SUSBSTITUIDOS, NOMEADAMENTE DERIVADOS DE QUINAZOLINA, PROCESSO PARA A SUA PREPARACAO E SUA UTILIZACAO</title><date>1999-07-30</date><risdate>1999</risdate><abstract>There are disclosed compounds of the general formula I: I wherein A is -CR7=CR8-; Z is -CR7=CR8-; X is H, NR 9R10, OR11, CN, F, Cl, I, Br, perfluoroalkyl, alkyl,alkoxy, alkyl-OH, alkoxyalkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; Y is NR13,NR13CR12R14, CR12R14NR13; R1 is 5-tetrazolyl, CO2R11,SO3H, NHSO2CH3, NHSO2CF3; R2,R3,R4,R7R8 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R13, -(CH2)nCO2R11,-(CH2)nCONR9R10, OR11,F,Cl,Br,I,NR9R10; R5 is alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, H, -CN, NO2, SO2R13,-(CH2)nCO2R11, -(CH2)nCONR9R10, -OH,OR11,F,Cl,Br,I,NR9R10; R9,R10 is H, alkyl, alkoxyalkyl,alkyl-OH, perfluoroalkyl, aralkyl; R11 is H, alkyl, aralkyl, alkoxyalkyl; R12,R14 is H, alkyl, alkoxy, alkoxyalkyl, alkyl-OH, perfluoroalkyl, aralkyl, CN, NO2, SO2R13, -(CH2)nCO2R11, -(CH2)nCONR9R10; R13 is H, OR11, alkyl, perfluoroalkyl, aralkyl, -(CH2)nCO2R11,-(CH2)nCONR9R10; wherein alkyl is defined as 1-8 carbons, branched or straight chain; perfluoroalkyl is defined as 1-6 carbons; aralkyl is defined as 7-12 carbons or 7-12 carbons substituted with fluorine, bromine or chlorine and the phamaceutically acceptable salts, solvates and hydrates thereof, which by virtue of their ability to antagonize angiotensin II are useful for the treatment of hypertension and congestive heart-failure. The compounds are also useful for reducing lipid levels in the blood plasma and are thus useful for treating hyperlipidemia and hypercholesterolemia. Also disclosed are processes for the production of said compounds and pharmaceutical compositions containing said compounds.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_PT100993B
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title HETEROCICLOS SUSBSTITUIDOS, NOMEADAMENTE DERIVADOS DE QUINAZOLINA, PROCESSO PARA A SUA PREPARACAO E SUA UTILIZACAO
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T11%3A36%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOHN%20LAURENT%20PRIMEAU&rft.date=1999-07-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT100993B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true